Sirid-Aimee Kellermann
Amgen
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sirid-Aimee Kellermann.
Current Opinion in Biotechnology | 2002
Sirid-Aimee Kellermann; Larry Green
Technical advances made in the 1980s and early 1990s resulted in monoclonal antibodies that are now approved for human therapy. Novel transgenic mouse strains provide a powerful technology platform for creating fully human monoclonal antibodies as therapeutics; ten such antibodies have entered clinical trials since 1998 and more are in preclinical testing. Improved transgenic mouse strains provide a powerful technology platform for creating human therapeutics in the future.
Archive | 2004
Vahe Bedian; Madhav Narasimha Devalaraja; Ian Foltz; Mary Haak-Frendscho; Sirid-Aimee Kellermann; Joseph Edwin Low; James Leslie Mobley
Archive | 2006
Sirid-Aimee Kellermann; Shelley Sims Belouski; Larry Green; Orit Foord
Archive | 2004
Vahe Bedian; Madhav Narasimha Devalaraja; Joseph Edwin Low; James Leslie Mobley; Sirid-Aimee Kellermann; Ian Foltz; Mary Haak-Frendscho
Archive | 2005
Sirid-Aimee Kellermann; Larry Green; Wouter Korver
Archive | 2007
Vahe Bedian; Madhav Narasimha Devalaraja; Ian Foltz; Mary Haak-Frendscho; Sirid-Aimee Kellermann; Joseph Edwin Low; James Leslie Mobley
Archive | 2005
Sirid-Aimee Kellermann; Larry Green; Mary Haak-Frendscho; Elizabeth Molloy; Nicolas Pullen
Archive | 2012
Sirid-Aimee Kellermann; Larry Green; Wouter Korver
Archive | 2010
Vahe Bedian; Madhav Narasimha Devalaraja; Ian Foltz; Mary Haak-Frendscho; Sirid-Aimee Kellermann; Joseph Edwin Low; James Leslie Mobley
Archive | 2006
Michael Aidan North; Jianying Wang; Grant Raymond Wickman; Jingchuan Zhang; Karin Kristina Amundson; Vahe Bedian; Shelley Sims Belouski; Dana Hu-Lowe; Xin Jiang; Shannon Marie Karlicek; Sirid-Aimee Kellermann; James Arthur Thomson
